idebenone has been researched along with Atherogenesis in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Idebenone treatment effectively stabilized the atherosclerotic plaques." | 5.62 | Idebenone Protects against Atherosclerosis in Apolipoprotein E-Deficient Mice Via Activation of the SIRT3-SOD2-mtROS Pathway. ( Geng, H; Jiang, W; Lin, P; Liu, F; Lv, X; Ma, J; Yan, C, 2021) |
| "Idebenone treatment effectively stabilized the atherosclerotic plaques." | 1.62 | Idebenone Protects against Atherosclerosis in Apolipoprotein E-Deficient Mice Via Activation of the SIRT3-SOD2-mtROS Pathway. ( Geng, H; Jiang, W; Lin, P; Liu, F; Lv, X; Ma, J; Yan, C, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, W | 1 |
| Geng, H | 1 |
| Lv, X | 1 |
| Ma, J | 1 |
| Liu, F | 1 |
| Lin, P | 1 |
| Yan, C | 1 |
1 other study available for idebenone and Atherogenesis
| Article | Year |
|---|---|
Idebenone Protects against Atherosclerosis in Apolipoprotein E-Deficient Mice Via Activation of the SIRT3-SOD2-mtROS Pathway.
Topics: Animals; Apolipoproteins E; Apoptosis; Atherosclerosis; Cell Survival; Human Umbilical Vein Endothel | 2021 |